ZA95669B - Analogs of thymosin alpha1 - Google Patents

Analogs of thymosin alpha1

Info

Publication number
ZA95669B
ZA95669B ZA95669A ZA95669A ZA95669B ZA 95669 B ZA95669 B ZA 95669B ZA 95669 A ZA95669 A ZA 95669A ZA 95669 A ZA95669 A ZA 95669A ZA 95669 B ZA95669 B ZA 95669B
Authority
ZA
South Africa
Prior art keywords
analogs
thymosin
thymosin alpha1
alpha1
compounds
Prior art date
Application number
ZA95669A
Other languages
English (en)
Inventor
Su-Sun Wang
Original Assignee
Alpha 1 Biomedicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha 1 Biomedicals Inc filed Critical Alpha 1 Biomedicals Inc
Publication of ZA95669B publication Critical patent/ZA95669B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compression, Expansion, Code Conversion, And Decoders (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Saccharide Compounds (AREA)
ZA95669A 1994-01-28 1995-01-27 Analogs of thymosin alpha1 ZA95669B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/188,232 US6262230B1 (en) 1994-01-28 1994-01-28 Analogs of thymosin α1

Publications (1)

Publication Number Publication Date
ZA95669B true ZA95669B (en) 1996-07-29

Family

ID=22692289

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA95669A ZA95669B (en) 1994-01-28 1995-01-27 Analogs of thymosin alpha1

Country Status (15)

Country Link
US (1) US6262230B1 (da)
EP (2) EP1688431A3 (da)
JP (2) JPH09508387A (da)
AT (1) ATE315583T1 (da)
AU (1) AU1568995A (da)
CA (1) CA2181477C (da)
DE (1) DE69534740T2 (da)
DK (1) DK0741746T3 (da)
ES (1) ES2259439T3 (da)
MY (1) MY114151A (da)
PE (1) PE29797A1 (da)
PT (1) PT741746E (da)
TW (1) TW396161B (da)
WO (1) WO1995020602A2 (da)
ZA (1) ZA95669B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101166761A (zh) * 2005-05-04 2008-04-23 隆萨股份公司 肽合成法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL176255C (nl) * 1971-07-01 1985-03-18 Hoechst Ag Werkwijze voor het bereiden van peptiden.
US4079127A (en) 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
CH641152A5 (en) * 1977-04-22 1984-02-15 Hoffmann La Roche Process for preparing thymosin alpha-1 and an analogue
US4116951A (en) 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
US4148788A (en) 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
DE3100974A1 (de) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
US4612365A (en) * 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4659694A (en) * 1983-10-27 1987-04-21 Hoffmann-La Roche Inc. Prothymosin alpha
US4855407A (en) * 1985-04-11 1989-08-08 Alpha-1 Biomedicals, Inc. Solid phase process for synthesizing peptides
ATE136551T1 (de) * 1988-05-10 1996-04-15 Alpha 1 Biomedicals Inc Festphase-verfahren zur gewinnung von thymosin- alpha-1

Also Published As

Publication number Publication date
TW396161B (en) 2000-07-01
PE29797A1 (es) 1997-09-01
EP1688431A2 (en) 2006-08-09
CA2181477C (en) 2002-01-01
DE69534740D1 (en) 2006-04-06
EP1688431A3 (en) 2006-11-29
US6262230B1 (en) 2001-07-17
HK1013296A1 (en) 1999-08-20
WO1995020602A3 (en) 1995-10-12
ES2259439T3 (es) 2006-10-01
DE69534740T2 (de) 2006-11-02
JPH09508387A (ja) 1997-08-26
PT741746E (pt) 2006-05-31
EP0741746B1 (en) 2006-01-11
JP2006160751A (ja) 2006-06-22
AU1568995A (en) 1995-08-15
ATE315583T1 (de) 2006-02-15
WO1995020602A2 (en) 1995-08-03
EP0741746A1 (en) 1996-11-13
JP3931194B2 (ja) 2007-06-13
CA2181477A1 (en) 1995-08-03
DK0741746T3 (da) 2006-05-29
MY114151A (en) 2002-08-30

Similar Documents

Publication Publication Date Title
IT1236831B (it) Apparecchio per il trattamento dell'intestino in particolare per enteroclisma
MA21682A1 (fr) Procede de preparation d'agents therapeutiques derives de la quainclidine.
GB2247837B (en) Pharmaceutical product for the treatment of immunoregulatory disorders
SG55090A1 (en) 3-Arylcarbonyl-1H-indoles useful as therapeutic agents
ZA928162B (en) Antibodies in immunosuppression.
FR2720070B1 (fr) Procédé de préparation d'alkylpolysiloxanes pontés et alkylpolysiloxanes pontés.
FI961378L (fi) Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi
GB2216416B (en) Nucleobase source for the stimulation of the immune system
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
IL89430A0 (en) Process for the preparation of 4,4'-dibromodiphenyl
EP0372282A3 (en) Process for the preparation of 1,5-dihydroxy and 1,5 diaminonaphthalene
GB9013868D0 (en) Spinal traction machine for self-application of traction
ZA929879B (en) Compositions for the treatment of mammalian diseases.
FR2620702B1 (fr) Procede de preparation d'irones naturelles
AU1568995A (en) Analogs of thymosin alpha1
EP0534449A3 (en) Process for the preparation of 3-aminomethyl-3,5,5-trialkylcyclohexylamine
ITMI931371A0 (it) Procedimento per la preparazione dell'erdosteina
ITMI942673A0 (it) Precesso per la (co) polinerizzazione dell'etilene
DE69305883D1 (de) Verfahren zur Herstellung von 2,6-Dimethylnaphthalin
AR245225A1 (es) Composiciones para el tratamiento de cuero.
EP0412938A3 (en) System for the treatment of contactlenses
GB9016062D0 (en) Process for the preparation of acrylates
FR2616038B1 (fr) Appareil pour l'etude de la photosynthese
IT1243274B (it) Procedimento per l'applicazione dello sperone e calzature costruite secondo il procedimento.
CS267587A1 (en) Equipment for materials' dynamic treatment